4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics develops experimental medicines using a technology called adeno-associated virus vectors, which are tiny packages designed to deliver genetic material into cells to treat disease. The company's main focus is treating eye diseases like wet age-related macular degeneration and diabetic macular edema by injecting these vectors into the eye to produce healing proteins over multiple years. They are also testing this approach for cystic fibrosis, a genetic lung disease, and for other genetic conditions affecting the lungs and eyes. The company was founded in 2013 and is sti...